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P U B L I S H E D B Y E L S E V I E R I N C .LettersNormalization of Visceral
Fat and Complete
Reversal of Cardiovascular
Remodeling Accompany
Gastric Bypass, not BandingAlthough bariatric surgery is highly effective in
reducing total body fat, Roux-en-Y gastric bypass
(RYGB) proportionally reduces abdominal visceral fat
more than laparoscopic adjustable gastric banding
(LAGB) (1). Because visceral fat depots are more
strongly linked to increased cardiometabolic risk, left
ventricular (LV) remodeling, and vascular stiffness (2),
this suggests that RYGB should result in greater car-
diovascular beneﬁts than LAGB. We sought to: 1)
compare improvements in cardiovascular structure
and function following RYGB and LAGB; and 2) deter-
mine if visceral fat is reduced toward normal levels, a
return to normal bodymass index (BMI) is necessary to
completely reverse the cardiovascular remodeling in
obesity.
One hundred thirty-ﬁve participants (26 pre-bariatric
surgery, 36 obese control subjects, 73 normal weight
subjects) underwent body composition analysis with
dual-energy x-ray absorptiometry and magnetic
resonance imaging assessment of abdominal visceral
fat and cardiovascular magnetic resonance assess-
ment of LV mass, LV concentric remodeling (LV
mass-to-volume ratio [LVMVR]), and regional aortic
distensibility (AD), as previously described (3). All
26 bariatric patients were re-studied after surgery
(14 RYGB, 12 LAGB; mean 854  383 days; no dif-
ference in follow-up time; p > 0.20). Exclusion
criteria included hypertension (>140/90 mm Hg),
diabetes (glucose $6.7 mmol/l), hypercholesterolemia
(total $6.5 mmol/l), smoking, and previous weight
reduction surgery.
All statistics were analyzed using SPSS 20 (IBM,
Armonk, New York). All data were normally distrib-
uted. Independent, paired Student t tests and 1-way
analysis of variance with Bonferroni’s correction were
performed to compare groups. A p < 0.05 was
considered signiﬁcant.Before surgery, although BMI was higher in the
RYGB group compared with the LAGB group (46.8 
5.6 kg/m2 vs. 41.1  4.8 kg/m2; p ¼ 0.01), body fat
percentage (52.3  24.7% vs. 48.9  22.2%; p ¼ 0.19),
total fat (66.3  14.2 kg vs. 56.3  12.6 kg; p ¼ 0.07),
visceral fat (173.8  63.5 cm2 vs. 140.0  70.0 cm2;
p ¼ 0.21), glucose (5.3  0.7 mmol/l vs. 5.3 
0.7 mmol/l; p > 0.99), cholesterol (5.1  0.8 mmol/l
vs. 5.1  0.6 mmol/l; p ¼ 0.7), and systolic blood
pressure (129  12 mm Hg vs. 119  144 mm Hg;
p ¼ 0.05) were similar. LV mass (134.4  25.1 g vs.
127.5  24.4 g; p ¼ 0.48), LVMVR (0.89  0.18 vs. 0.84
 0.14; p ¼ 0.45), and regional AD (ascending aorta:
4.2  2.0 mm Hg1 vs. 5.8  3.5 mm Hg1, p ¼ 0.18;
proximal descending aorta [PDA]: 3.7  1.5 mm Hg1
vs. 4.6  2.2 mm Hg1; p ¼ 0.21; abdominal aorta
[DDA]: 4.7  1.4 mm Hg1 vs. 6.2  3.1 mm Hg1;
p ¼ 0.13) were also similar between surgical groups.
Although BMI change was greater with RYBG (14.0
 4.6 kg/m2 vs. 8.5  3.2 kg/m2; p 0.02), post-
operative BMI (RYGB 32.7  4.7 kg/m2 vs. LAGB 32.6
 5.6 kg/m2; p ¼ 0.94) and total fat loss (RYGB
41.0  11.1% vs. LAGB 33.4  18.2%; p ¼ 0.92) were
similar. Visceral fat loss expressed as a percentage
(RYGB 61.6  11.8% vs. LAGB 31.1  18.1%; p < 0.001)
and relative to the total fat loss (RYGB 1.6  0.5 vs.
LAGB 1.0  0.6; p ¼ 0.02) were greater following
RYGB. RYGB also resulted in greater improvements in
cholesterol (4.4  0.8 mmol/l vs. 5.3  0.9 mmol/l;
p ¼ 0.04), and systolic blood pressure (11.6 
9.4 mm Hg vs. 1.1  10.7 mm Hg; p < 0.01).
Although both RYGB and LAGB reduced LV mass
(by 23% and 15%, respectively; p < 0.01 for both) and
LVMVR (by 12% and 17%, respectively; p < 0.01),
RYGB was associated with a greater LV mass reduc-
tion (by 8%, p ¼ 0.049) and greater improvement in
abdominal AD (59%, p ¼ 0.05).
Compared with an age- and sex-matched cohort
with similar BMI (32.7  4.7 kg/m2 vs. 33.7  3.1 kg/m2;
p ¼ 0.77) and total fat (38.1  7.7 kg vs. 38.5  7.2 kg;
p > 0.99) patients following RYGB had 47% lower
visceral fat (p < 0.001). Despite remaining obese,
visceral fat following RYGB was reduced to the same
level as age- and sex-matched normal weight controls
(Figure 1). LV mass (102.5  21.9 g vs. 122.4  29.5 g;
p ¼ 0.03) and LVMVR (post-RYGB 0.73  0.03 vs. 0.84
 0.02; p ¼ 0.004) were also both lower than BMI- and
FIGURE 1 The Effect of Roux-en-Y Gastric Bypass on Cardiovascular Remodeling
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2570fat mass–matched obese control subjects, and regional
AD better (PDA 5.9 1.8mmHg1 vs. 4.6 1.6mmHg1;
DDA 8.5  2.8 mm Hg1 vs. 6.4  2.4 mm Hg1; both
p< 0.05). Again, although still obese, LV mass (102.6 
18.7 g vs. 103 29.4 g; p>0.99), LVMVR (0.730.12 vs.
0.75  0.13; p > 0.99), and regional AD (PDA and DDA;
p > 0.43) were all similar to those in normal weight
control subjects (Figure 1).
The medium term effects of 2 common forms of
bariatric surgery on cardiovascular remodeling are
assessed in this pilot study. We have shown that RYGB
results in greater reduction in abdominal visceral fat,
and greater reversal of LV remodeling and aortic
stiffness than LAGB. Furthermore, we have shown
that although remaining obese following RYGB, LV
mass, concentric remodeling, and aortic elastic func-
tion return to normal. Overall, this suggests that as
long as visceral fat is reduced, a return to normal BMI
is not necessary for complete resolution of the car-
diovascular structural and functional changes in
obesity. Larger studies are needed to conﬁrm these
ﬁndings and establish how the reduction in abdominal
visceral fat mediates these improvements indepen-
dently from other fat depots.Jennifer J. Rayner, BMBCh, BA
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